{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T20:41:47Z","timestamp":1771620107394,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001316","name":"Abbott","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DexCom Inc"},{"DOI":"10.13039\/100014592","name":"Insulet","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014592","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Lilly Diabetes Excellent Center"},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jpeds.2019.06.002","type":"journal-article","created":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T07:43:10Z","timestamp":1563781390000},"page":"216-222.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Proportion of Basal to Total Insulin Dose Is Associated with Metabolic Control, Body Mass Index, and Treatment Modality in Children with Type 1 Diabetes\u2014A Cross-Sectional Study with Data from the International SWEET Registry"],"prefix":"10.1016","volume":"215","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1356-2833","authenticated-orcid":false,"given":"Vinni Faber","family":"Rasmussen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esben Thyssen","family":"Vestergaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke","family":"Schwandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Beltrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Rami-Merhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.P.","family":"O'Riordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Przemyslawa","family":"Jarosz-Chobot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cintia","family":"Castro-Correia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelien F.","family":"Gevers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels H.","family":"Birkeb\u00e6k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 27","key":"10.1016\/j.jpeds.2019.06.002_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/pedi.12718","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: insulin treatment in children and adolescents with diabetes","volume":"19","author":"Danne","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jpeds.2019.06.002_bib2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1651-2227.2008.01151.x","article-title":"Age-dependent basal insulin patterns in children with type 1 diabetes treated with continuous subcutaneous insulin infusion","volume":"98","author":"Szypowska","year":"2009","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jpeds.2019.06.002_bib3","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.2337\/dc12-1705","article-title":"Predicting the optimal basal insulin infusion pattern in children and adolescents on insulin pumps","volume":"36","author":"Holterhus","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpeds.2019.06.002_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-5448.2011.00777.x","article-title":"Basal rates and circadian profiles in continuous subcutaneous insulin infusion (CSII) differ for preschool children, prepubertal children, adolescents and young adults","volume":"13","author":"Bachran","year":"2012","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jpeds.2019.06.002_bib5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1055\/s-2007-990296","article-title":"Age-specific characteristics of the basal insulin-rate for pediatric patients on CSII","volume":"116","author":"Klinkert","year":"2008","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.jpeds.2019.06.002_bib6","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/pedi.12173","article-title":"The basal insulin dose; a lesson from prolonged fasting in young individuals with type 1 diabetes","volume":"16","author":"Strich","year":"2015","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jpeds.2019.06.002_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/dia.2016.0421","article-title":"Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes","volume":"19","author":"Garg","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jpeds.2019.06.002_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/dia.2018.0264","article-title":"Safety evaluation of the minimed 670g system in children 7-13 years of age with type 1 diabetes","volume":"21","author":"Forlenza","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jpeds.2019.06.002_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jpeds.2016.11.029","article-title":"Lower basal insulin dose is associated with better control in type 1 diabetes","volume":"182","author":"Strich","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2019.06.002_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/pedi.12352","article-title":"Lower dose basal insulin infusion has positive effect on glycaemic control for children with type I diabetes on continuous subcutaneous insulin infusion therapy","volume":"18","author":"Schulten","year":"2017","journal-title":"Pediatr Diabetes"},{"issue":"3 Pt 1","key":"10.1016\/j.jpeds.2019.06.002_bib11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1399-5448.2008.00375.x","article-title":"Basal insulin and total daily insulin dose in children with type 1 diabetes using insulin pumps","volume":"9","author":"Pankowska","year":"2008","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jpeds.2019.06.002_bib12","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1007\/s00125-008-1072-2","article-title":"Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries","volume":"51","author":"Danne","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.jpeds.2019.06.002_bib13","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.2337\/dc07-9922","volume":"30","author":"Phillip","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpeds.2019.06.002_bib14","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/pedi.12693","article-title":"Body mass index standard deviation score and obesity in children with type 1 diabetes in the Nordic countries. HbA1c and other predictors of increasing BMISDS","volume":"19","author":"Birkebaek","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jpeds.2019.06.002_bib15","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jpeds.2015.05.046","article-title":"Obesity in youth with type 1 diabetes in Germany, Austria, and the United States","volume":"167","author":"DuBose","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2019.06.002_bib16","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/pedi.12730","article-title":"Prevalence of underweight, overweight, and obesity in children and adolescents with type 1 diabetes: data from the international SWEET registry","volume":"19","author":"Maffeis","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jpeds.2019.06.002_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40200-016-0271-5","article-title":"Excess weight gain during insulin pump therapy is associated with higher basal insulin doses","volume":"15","author":"Boucher-Berry","year":"2016","journal-title":"J Diabetes Metab Disord"},{"issue":"Suppl 16","key":"10.1016\/j.jpeds.2019.06.002_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1399-5448.2012.00914.x","article-title":"Criteria for Centers of Reference for pediatric diabetes--a European perspective","volume":"13","author":"Danne","year":"2012","journal-title":"Pediatr Diabetes"},{"issue":"Suppl 23","key":"10.1016\/j.jpeds.2019.06.002_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/pedi.12432","article-title":"Possibilities and challenges of a large international benchmarking in pediatric diabetology-The SWEET experience","volume":"17","author":"Witsch","year":"2016","journal-title":"Pediatr Diabetes"},{"issue":"Suppl 27","key":"10.1016\/j.jpeds.2019.06.002_bib20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/pedi.12698","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: assessment and management of hypoglycemia in children and\u00a0adolescents with diabetes","volume":"19","author":"Abraham","year":"2018","journal-title":"Pediatr Diabetes"},{"issue":"Suppl 27","key":"10.1016\/j.jpeds.2019.06.002_bib21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/pedi.12701","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state","volume":"19","author":"Wolfsdorf","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jpeds.2019.06.002_bib22","first-page":"76","article-title":"WHO Child Growth Standards based on length\/height, weight and age","volume":"450","year":"2006","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.jpeds.2019.06.002_bib23","doi-asserted-by":"crossref","first-page":"660","DOI":"10.2471\/BLT.07.043497","article-title":"Development of a WHO growth reference for school-aged children and adolescents","volume":"85","author":"de Onis","year":"2007","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jpeds.2019.06.002_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/dc13-2112","article-title":"The diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: overview","volume":"37","author":"Nathan","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpeds.2019.06.002_bib25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM200002103420603","article-title":"Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy","volume":"342","author":"Lachin","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2019.06.002_bib26","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2337\/diacare.18.11.1415","article-title":"Adverse events and their association with treatment regimens in the diabetes control and complications trial","volume":"18","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpeds.2019.06.002_bib27","doi-asserted-by":"crossref","first-page":"e000377","DOI":"10.1136\/bmjdrc-2016-000377","article-title":"Incidence of severe hypoglycemia in children with type 1 diabetes in the Nordic countries in the period 2008-2012: association with hemoglobin A 1c and treatment modality","volume":"5","author":"Birkebaek","year":"2017","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.jpeds.2019.06.002_bib28","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/pedi.12477","article-title":"Severe hypoglycemia rates are not associated with HbA1c: a cross-sectional analysis of 3 contemporary pediatric diabetes registry databases","volume":"18","author":"Haynes","year":"2017","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jpeds.2019.06.002_bib29","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.2337\/dc13-0418","article-title":"Residual beta-Cell function 3-6 years after onset of type 1 diabetes reduces risk of severe hypoglycemia in children and adolescents","volume":"36","author":"Sorensen","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpeds.2019.06.002_bib30","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2337\/dc14-1952","article-title":"Prevalence of detectable C-peptide according to age at diagnosis and duration of type 1 diabetes","volume":"38","author":"Davis","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpeds.2019.06.002_bib31","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/pedi.12275","article-title":"Classifying insulin regimens\u2014difficulties and proposal for comprehensive new definitions","volume":"16","author":"Neu","year":"2015","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jpeds.2019.06.002_bib32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2337\/diaclin.33.3.123","article-title":"Insulin therapy: a personal approach","volume":"33","author":"Davidson","year":"2015","journal-title":"Clin Diabetes"},{"key":"10.1016\/j.jpeds.2019.06.002_bib33","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s001250050944","article-title":"Contributions of age, gender and insulin administration to weight gain in subjects with IDDM","volume":"41","author":"Holl","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.jpeds.2019.06.002_bib34","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1515\/JPEM.2002.15.5.607","article-title":"Weight in adolescents with type 1 diabetes mellitus during continuous subcutaneous insulin infusion (CSII) therapy","volume":"15","author":"Raile","year":"2002","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2019.06.002_bib35","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1136\/archdischild-2013-304237","article-title":"Predictors of increasing BMI during the course of diabetes in children and adolescents with type 1 diabetes: data from the German\/Austrian DPV multicentre survey","volume":"99","author":"Frohlich-Reiterer","year":"2014","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jpeds.2019.06.002_bib36","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2337\/dc10-2149","article-title":"Basal insulin requirement is \u223c30% of the total daily insulin dose in type 1 diabetic patients who use the insulin pump","volume":"34","author":"Kuroda","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpeds.2019.06.002_bib37","doi-asserted-by":"crossref","first-page":"27090","DOI":"10.1074\/jbc.M109.016675","article-title":"Insulin is a stronger inducer of insulin resistance than hyperglycemia in mice with type 1 diabetes mellitus (T1DM)","volume":"284","author":"Liu","year":"2009","journal-title":"J Biol Chem"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347619306961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347619306961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:01:51Z","timestamp":1758358911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347619306961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":37,"alternative-id":["S0022347619306961"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2019.06.002","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proportion of Basal to Total Insulin Dose Is Associated with Metabolic Control, Body Mass Index, and Treatment Modality in Children with Type 1 Diabetes\u2014A Cross-Sectional Study with Data from the International SWEET Registry","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2019.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2019.07.030","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}